There is an unmet clinical need for effective treatment of paroxysmal nocturnal hemoglobinuria (PNH) in pregnancy for patients with inadequate response to C5 inhibitors. The gene discussed is C5; the disease is paroxysmal nocturnal hemoglobinuria.